Nkarta, Inc. (NKTX)
3.25
-0.05
(-1.52%)
USD |
NASDAQ |
May 29, 16:00
3.24
-0.01
(-0.31%)
Pre-Market: 20:00
Nkarta EPS Diluted (Quarterly) : -0.3748 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Gilead Sciences, Inc. | 1.612 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| ADMA Biologics, Inc. | 0.1889 |
| Zenas BioPharma, Inc. | -1.456 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.83M |
| Total Expenses (Quarterly) | 27.83M |
| Enterprise Value | 77.09M |
| Earnings Yield | -41.51% |
| Normalized Earnings Yield | -41.50 |